Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cue Biopharma, Inc. (1UC.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
3.2000+0.0600 (+1.91%)
At close: 09:15AM CET
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in USD. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
9,348
14,941
3,154
3,458
Operating Expense
55,858
58,653
48,197
40,228
Operating Income
-46,510
-43,712
-45,043
-36,769
Net Non Operating Interest Income Expense
-55.102
45.898
463.914
418.712
Other Income Expense
64.078
-
-
64.078
Pretax Income
-46,307
-43,666
-44,579
-36,286
Tax Provision
-
495
206.25
412.5
Net Income Common Stockholders
-46,802
-44,161
-44,785
-36,699
Diluted NI Available to Com Stockholders
-46,802
-44,161
-44,785
-36,699
Basic EPS
-
-1.41
-1.56
-1.66
Diluted EPS
-
-1.41
-1.56
-1.66
Basic Average Shares
-
31,285
28,689
22,042
Diluted Average Shares
-
31,285
28,689
22,042
Total Operating Income as Reported
-46,252
-43,712
-45,043
-36,769
Total Expenses
55,858
58,653
48,197
40,228
Net Income from Continuing & Discontinued Operation
-46,802
-44,161
-44,785
-36,699
Normalized Income
-47,060
-44,161
-44,785
-36,699
Interest Income
299.898
45.898
463.914
418.712
Net Interest Income
-55.102
45.898
463.914
418.712
EBIT
-45,998
-43,712
-45,043
-36,769
EBITDA
-45,998
-
-
-
Reconciled Depreciation
-4,905
-1,778
1,057
5,166
Net Income from Continuing Operation Net Minority Interest
-46,802
-44,161
-44,785
-36,699
Total Unusual Items Excluding Goodwill
258
-
-
-
Total Unusual Items
258
-
-
-
Normalized EBITDA
-46,256
-43,712
-43,985
-31,604
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement